Literature DB >> 32828129

Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial.

Javed Akram1, Shehnoor Azhar2, Muhammad Shahzad3, Waqas Latif4, Khalid Saeed Khan5.   

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Entities:  

Year:  2020        PMID: 32828129      PMCID: PMC7442885          DOI: 10.1186/s13063-020-04697-1

Source DB:  PubMed          Journal:  Trials        ISSN: 1745-6215            Impact factor:   2.279


Correction to: Trials 21, 702 (2020) https://doi.org/10.1186/s13063-020-04616-4 Following publication of the original article [1], we were notified that the authors would like to modify the article title to “Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial”, as it is conceptually and grammatically more accurate and reflective of the nature and topic.

北京卡尤迪生物科技股份有限公司 © 2022-2023.